EUVIMEDEUVIMED entdecken
Open Access

A distinct subset of stem-cell memory is poised for the cytotoxicity program in CD4 + T cells in humans

Raunak Kar iD, Shreya Sinha, Zainab Khatun, Anjali Sharma, Veena S Patil iD

Science Advances · 2026

DOI: 10.1126/sciadv.ady6423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Raunak Kar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunogenomics Lab, National Institute of Immunology, New Delhi, Delhi, India. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Immunologic Memory, Cytotoxicity, Immunologic, Stem Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: DBT-Wellcome Trust India Alliance, DBT India Alliance, BRIC-NII Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CD4 + cytotoxic T lymphocytes (CD4-CTLs) with cytotoxic potential are reported to be the components of protective immune response in many diseases. However, the lack of understanding about their lineage, molecular character, and cytolytic potential in comparison to CD8 + (CD8)-CTLs has restricted their utility. Thus, here, by parallelly analyzing the human peripheral CD4-CTLs and CD8-CTLs, we demonstrate that they are indistinguishable for the cytotoxic program. Furthermore, using an integrative multiomics approach combining the transcriptome, T cell antigen-receptor repertoire, and open chromatin profile of CD4 + T cell memory subsets, we found a stem-cell memory subset that is precommitted to the cytotoxicity program. Through an in vitro differentiation model, we developed CD4 + T cells with cytolytic potential coexpressing and exhibiting progressive chromatin accessibility for cytotoxicity- and longevity-associated genes, hence generating long-lived CD4-CTL effectors of varying cytotoxic capacity. Together, our study advocates for exploring both CD4-CTLs and CD8-CTLs for vaccine development, vaccine efficacy testing, and immunotherapies and cell-based therapies for precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesImmunologic MemoryCytotoxicity, ImmunologicStem CellsHumansCell DifferentiationT-Lymphocytes, CytotoxicCD8-Positive T-LymphocytesGene Expression ProfilingTranscriptome

Autor:innen und Institutionen

  • Immunogenomics Lab, National Institute of Immunology, New Delhi, Delhi, India.
  • Department of Transfusion Medicine and Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, Delhi, India.

ORCID-Profile: Raunak Kar, Veena S Patil

Förderung

  • DBT-Wellcome Trust India Alliance
  • DBT India Alliance
  • BRIC-NII Institute
  • DBT-JRF

Zitieren

APA

Kar, R., Sinha, S., Khatun, Z., Sharma, A., & Patil, V. S. (2026). A distinct subset of stem-cell memory is poised for the cytotoxicity program in CD4 + T cells in humans. Science Advances. https://doi.org/10.1126/sciadv.ady6423

Vancouver

Kar R, Sinha S, Khatun Z, Sharma A, Patil VS. A distinct subset of stem-cell memory is poised for the cytotoxicity program in CD4 + T cells in humans. Science Advances. 2026. doi:10.1126/sciadv.ady6423

BibTeX
@article{Kar2026,
  author = {Kar, Raunak and Sinha, Shreya and Khatun, Zainab and Sharma, Anjali and Patil, Veena S},
  title = {A distinct subset of stem-cell memory is poised for the cytotoxicity program in CD4 + T cells in humans},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.ady6423}
}
Kostenlos starten →